Welcome to the Symeres Whitepapers section, where cutting-edge science meets real-world application.
At Symeres, we are committed to pushing the boundaries of drug discovery and drug development. Our whitepapers are crafted to share in-depth knowledge, innovative methodologies, and valuable insights that stem from our extensive expertise in supporting pharmaceutical and biotechnology industries worldwide for many years. Making Molecules Matter. Together.
New whitepapers are on the way and will be available soon. Stay tuned!
Do you have any further questions? Feel free to contact us at: science@symeres.com
IND & IMPD Enabling Developability Roadmap
At Symeres, we designed our proprietary Developability Roadmap package to provide you with the information you need to enter development with a clear plan of action.
Innovations in Unnatural Amino Acids: Advancing Functional Diversity and Applications
This whitepaper highlights Symeres’ expertise in synthesizing unnatural amino acids, including side-chain modifications, N-functionalization, and cyclic variants, for applications in pharmaceuticals, diagnostics, and materials science.
Leveraging Copper-Catalyzed Ullmann-Type Cross-Coupling Reactions in PR&D
Our experience in overcoming scaleup challenges and harnessing the benefits of non-noble-metal catalysis makes Symeres the CRO of choice for challenging steps, such as the Ullmann reaction.
Managing Nitrosamines in the Pharmaceutical Industry: a Comprehensive Approach
A comprehensive overview of nitrosamine risk assessment, including potential formation, scavenging, and analysis, is described here.
Optimizing Solid-State Properties and Enhancing API Bioavailability through Physicochemical Prediction Here at Symeres, we have our new ‘Solid-State Center of Excellence’, and in this whitepaper we describe how we utilize our expertise and novel innovation to further our solid-state capabilities.
Stable Isotope-Labeled Compounds
Discover how Symeres applies advanced synthetic chemistry and ADME expertise to design, produce, and study stable isotope-labelled compounds that enhance precision in drug development.
Unlocking the Potential of High-Throughput Screening: Symegold Library Design and Expansion Insights
Learn how Symeres combines advanced chemistry platforms and deep discovery expertise to design and expand the SymeGold library, driving more efficient high-throughput screening and smarter hit identification.
Accelerating Chemical Innovation: Unveiling Symeres’ Parallel Chemistry
By combining automation, data-driven design, and deep synthetic expertise, Symeres is redefining how chemists generate and optimize compound libraries, bringing speed, scalability, and creativity to modern drug discovery.
